This may be because anti-PD-L1 antibody does not block PD-L2 induced PD-1 signal in T cells, and PD-L2 is also overexpressed and performs as a prognostic factor for HCC (75). The gene discussed is PDCD1; the disease is hepatocellular carcinoma.